Published in Br J Cancer on December 01, 1978
A prognostic index in primary breast cancer. Br J Cancer (1982) 7.35
The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease. Br J Cancer (1983) 4.33
Node negative breast cancer. BMJ (1990) 2.53
Metastatic progression of breast cancer: insights from 50 years of autopsies. J Pathol (2014) 1.27
Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases. Br J Cancer (1987) 1.23
Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis. Neoplasia (2010) 0.96
Pregnancy-associated plasma protein A. A clinically significant predictor of early recurrence in stage I breast carcinoma is independent of estrogen receptor status. Am J Pathol (1985) 0.85
Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast. Br J Cancer (1981) 0.84
Tumour epithelial cellularity and quantitative oestrogen receptor values in primary breast cancer. Br J Cancer (1983) 0.81
Steroid receptors in meningiomas. A histochemical and biochemical study. Acta Neuropathol (1983) 0.77
Racial disparities in survival and age-related outcome in postsurgery breast cancer patients in a new york city community hospital. ISRN Oncol (2014) 0.75
Association between hormone receptors and HER-2/neu is age-related. Int J Clin Exp Pathol (2015) 0.75
Hormone receptors and human breast cancer. Br Med J (1980) 0.75
Estrogen receptors and breast cancer. Environ Health Perspect (1981) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer (1957) 21.59
A two-step mechanism for the interaction of estradiol with rat uterus. Proc Natl Acad Sci U S A (1968) 4.77
Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes. Surg Gynecol Obstet (1955) 4.55
Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res (1977) 4.02
Hormone receptors: studies on the interaction of estrogen with the uterus. Recent Prog Horm Res (1968) 2.28
Pathological review of breast lesions analyzed for estrogen receptor protein. Cancer Res (1975) 2.24
Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting. Anal Biochem (1972) 1.84
Histology in breast cancer prognosis. Br J Cancer (1972) 1.58
The binding of estradiol-17beta to human breast cancers and other tissues in vitro. Cancer Res (1970) 1.27
Histological grading in carcinoma of the breast. Br J Cancer (1966) 1.11
Tumor grade in the prognosis of breast cancer. Nebr State Med J (1970) 0.98
The sequence of the human genome. Science (2001) 101.55
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
A prognostic index in primary breast cancer. Br J Cancer (1982) 7.35
The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat (1992) 6.51
Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem (1995) 6.25
Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J Clin Invest (1971) 6.09
Smoking, smoking cessation, and major depression. JAMA (1990) 5.89
Communication failures in patient sign-out and suggestions for improvement: a critical incident analysis. Qual Saf Health Care (2005) 5.55
Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res (1999) 5.35
Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science (1992) 4.53
Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite. J Cell Biol (1978) 4.50
Personal view. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears? Cytopathology (2001) 4.40
Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr Biol (1998) 4.13
Dependence on hypnotic drugs in general practice. Br Med J (1968) 3.88
Making self regulation credible. Through benchmarking, peer review, appraisal-and management. BMJ (1998) 3.84
Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol (2004) 3.80
An epidemiological study of disorders in late childhood and adolescence--I. Age- and gender-specific prevalence. J Child Psychol Psychiatry (1993) 3.54
The Arabidopsis NIM1 protein shows homology to the mammalian transcription factor inhibitor I kappa B. Plant Cell (1997) 3.40
Confirmation of a prognostic index in primary breast cancer. Br J Cancer (1987) 3.29
Mupirocin resistance. Lancet (1991) 2.88
Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg (1989) 2.84
Pharmacologic paralysis and withdrawal of mechanical ventilation at the end of life. N Engl J Med (2000) 2.81
Are patients with abnormal cervical smears adequately managed? Br Med J (Clin Res Ed) (1984) 2.78
Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology (1992) 2.75
Cardiac Resuscitation. Ann Surg (1948) 2.70
Relationship of oestrogen-receptor status to survival in breast cancer. Lancet (1979) 2.55
Relationship between primary breast tumor receptor status and patient survival. Cancer (1980) 2.49
Anticoccidial drugs: lesion scoring techniques in battery and floor-pen experiments with chickens. Exp Parasitol (1970) 2.40
The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. Br J Cancer (1982) 2.39
Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci U S A (1996) 2.39
Social phobia. Comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry (1992) 2.37
Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology (2002) 2.35
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol (2001) 2.21
A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol (1995) 2.20
A longitudinal analysis of selected risk factors for childhood psychopathology. J Am Acad Child Adolesc Psychiatry (1989) 2.20
Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study. Eur J Cancer (2001) 2.16
Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health (1988) 2.16
Oestrogen receptors and survival in early breast cancer. Br Med J (Clin Res Ed) (1981) 2.14
Phylogenetic relationships of agaric fungi based on nuclear large subunit ribosomal DNA sequences. Syst Biol (2000) 2.14
Evaluation of a telerobotic system to assist surgeons in microsurgery. Comput Aided Surg (1999) 2.13
A PEST-like element in FREQUENCY determines the length of the circadian period in Neurospora crassa. EMBO J (2001) 2.08
The Functional Independence Measure: a comparative validity and reliability study. Disabil Rehabil (1995) 2.04
Linkage analyses of murine immunoglobulin heavy chain and serum prealbumin genes establish their location on chromosome 12 proximal to the T (5;12) 31H breakpoint in band 12F1. Proc Natl Acad Sci U S A (1980) 2.03
Evaluation of a protocol for post-mortem examination of stillbirths. N Engl J Med (1983) 2.01
Disseminated candidiasis due to amphotericin B-resistant Candida albicans. J Infect Dis (1992) 2.01
A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation (1998) 1.97
Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. Br J Cancer (2004) 1.97
Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer (1989) 1.97
Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res (1978) 1.95
Painless left hemorrhagic pleural effusion: An unusual presentation of dissecting ascending aortic aneurysm. Chest (1999) 1.94
Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer (2007) 1.94
Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology (1995) 1.90
Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement. Mod Pathol (2000) 1.88
Possible origin of the high incidence of Clostridium botulinum type E in an inland bay (Green Bay of Lake Michigan). J Bacteriol (1968) 1.86
Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. Cancer Res (1990) 1.85
Depressive symptoms in women in the six months after miscarriage. Am J Obstet Gynecol (1992) 1.84
Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma. Br J Urol (1991) 1.83
Reading the prognosis of the individual with breast cancer. Eur J Cancer (2007) 1.83
Oestrogen receptors and prognosis in early breast cancer. Lancet (1979) 1.83
The psychological impact of immediate rather than delayed breast reconstruction. Eur J Surg Oncol (2000) 1.82
Screening interval breast cancers: mammographic features and prognosis factors. Radiology (1996) 1.82
Pulmonary veno-occlusive disease: a case series and new observations. Chest (2000) 1.80
Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology (1994) 1.78
Prognostic factors in breast cancer -- the formation of a prognostic index. Clin Oncol (1979) 1.74
Genetic analysis of NF1: identification of close flanking markers on chromosome 17. Genomics (1987) 1.73
A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterization. Histopathology (1984) 1.72
A randomized trial comparing 5-mg and 10-mg warfarin loading doses. Arch Intern Med (1999) 1.72
Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer (1996) 1.71
Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. Exp Hematol (1999) 1.71
Cytological grading of breast carcinoma--a feasible proposition? Cytopathology (1990) 1.70
Depressive symptoms as relative and attributable risk factors for first-onset major depression. Arch Gen Psychiatry (1992) 1.70
Characterization of the WIDR: a human colon carcinoma cell line. In Vitro (1979) 1.69
PRIMO: A primer design program that applies base quality statistics for automated large-scale DNA sequencing. Genomics (1997) 1.67